Page last updated: 2024-11-07

formycin triphosphate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

formycin triphosphate: formycin ATP analog [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID72941511
SCHEMBL ID18490376
MeSH IDM0101562

Synonyms (5)

Synonym
formycin triphosphate
formycin a 5'-triphosphate
d-ribitol, 1-c-(7-amino-1h-pyrazolo(4,3-d)pyrimidin-3-yl)-1,4-anhydro-, 5-(tetrahydrogen triphosphate), (1s)-
formycin 5'-triphosphate
SCHEMBL18490376
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (29)

TimeframeStudies, This Drug (%)All Drugs %
pre-199015 (51.72)18.7374
1990's13 (44.83)18.2507
2000's1 (3.45)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other29 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]